You can also read about it here
In early April 2025, the federal government and the Trump Administration announced that it wont be including anti-obesity medications like GLP-1s in Medicaid or Medicare coverage in 2026
Serum B12, folate, and methylmalonic acid levels reveal whether supplementation addresses an actual deficit or represents preventive dosing
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test examines genetic variation in GLP1R, GIPR, FTO, and MC4R pathwaysmarkers that may help provide context for how your body's receptor signaling machinery handles GLP-1 therapy at various unit doses
Harada, T., Swift, J., Irianto, J., Shin, J